Psychosocial issues associated with genetic testing for breast and ovarian cancer risk: An integrative review

Cancer Investigation

Volumn 21, Issue 4, 2003, Pages 588-623

  Pasacreta, Jeannie V ^a  

^a YALE UNIVERSITY SCHOOL OF NURSING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

BREAST CANCER; CANCER GENETICS; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; FAMILIAL CANCER; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC SCREENING; HUMAN; MEDICAL DECISION MAKING; MENTAL HEALTH; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SOCIAL PSYCHOLOGY;

BREAST NEOPLASMS; DECISION MAKING; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; OVARIAN NEOPLASMS; PATIENT EDUCATION; PEDIGREE; RISK ASSESSMENT; SOCIAL SUPPORT; STRESS, PSYCHOLOGICAL;

EID: 0141676664     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-120022380     Document Type: Review

References (68)

1. American Cancer Society; Cancer Statistics, 2001. CA 2001, 51, 15-36.
2. Rosenthal, T.C.; Puck, S.M. Screening for genetic risk of breast cancer. Am. Fam. Physician 1999, 59, 99-104.
3. Arver, B.; Du, Q.; Chen, J.; Luo, L.; Lindblom, A. Hereditary breast cancer: a review. Semin. Cancer Biol. 2000, 10, 271-288.
4. Goodwin, P.J. Management of familial breast cancer risk. Breast Cancer Res. Treat. 2000, 62, 19-33.
5. Hulka, B.S.; Moorman, P.G. Breast cancer: hormones and other risk factors. Maturitas 2001, 38, 103-116.
6. Newman, B.; Mu, H.; Butler, L.M.; Milliken, R.C.; Moorman, P.G.; King, M.C. Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. J. Am. Med. Assoc. 1998, 279, 915-921.
7. Miki, Y.; Swensen, J.; Shattuck-Eidens, D.; Futreal, P.A.; Harshman, K.; Tavtigian, S.; Liu, Q.; Cochran, C.; Bennett, L.M.; Ding, W.; Bell, R.; Rosenthal, J.; Hussey, C.; Tran, T.; McClure, M.; Frye, C.; Hattier, T.; Phelps, R.; Haugen-Strano, A.; Katcher, H.; Yakumo, K.; Gholami, I.; Shaffer, D.; Stone, S.; Bayer, S.; Wray, C.; Bogden, R.; Dayananth, P.; Ward, J.; Tonin, P.; Narod, S.; Bristow, P.K.; Norris, F.H.; Helvering, L.; Morrison, P.; Rosteck, P.; Lai, M.; Barrett, J.C.; Lewis, C.; Neuhausen, S.; Cannon-Albright, L.; Goldgar, D.; Wiseman, R.; Kamb, A.; Skolnick, M.H. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994, 266, 66-71.
8. Wooster, R.; Bignell, G.; Lancaster, J.; Swift, S.; Seal, S.; Manglon, J.; Collins, N.; Gregory, S.; Gumbs, C.; Micklem, G.; Barfoot, R.; Hamoudi, R.; Patel, S.; Rice, C.; Biggs, P.; Hashim, Y.; Smith, A.; Connor, F.; Arason, A.; Gudmundsson, J.; Ficenec, D.; Kelsell, D.; Ford, D.; Tonin, P.; Bishop, D.T.; Spurr, N.K.; Ponder, B.A.J.; Eeles, R.; Peto, J.; Devilee, P.; Comelisse, C.J.; Lynch, H.; Narod, S.; Lenoir, G.; Egilsson, V.; Barkadottir, R.B.; Easton, D.F. ; Bentley, D.R.; Futreal, P.A.; Ashworth, A.; Stratton, M.R. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995, 378, 789-792.
9. Blackwood, M.A.; Weber, B.L. BRCA1 and BRCA2: from molecular genetics to clinical medicine. J. Clin. Oncol. 1998, 16, 1969-1977.
10. Burke, W.; Daly, M.; Garber, J.; Botkin, J.; Ellis-Kahn, M.J.; Lynch, P. ; McTiernan, A.; Offit, K.; Perlman, J.; Petersen, G.; Thomson, E.; Varrichio, C. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. J. Am. Med. Assoc. 1997, 277, 997-1003.
11. Fasouliotis, S.J.; Schenker, J.G. BRCA1 and BRCA2 gene mutations: decision-making dilemmas concerning testing and management. Obstet. Gynecol. Survey 2000, 55, 373-384.
12. Iau, P.T.C.; Macmillan, R.D.; Blamey, R.W. Germ line mutations associated with breast cancer susceptibility. Eur. J. Cancer 2001, 37, 300-321.
13. Nathanson, K.L.; Wooster, R.; Weber, B.L. Breast cancer genetics: what we know and what we need. Nat. Med. 2001, 7, 552-556.
14. Croyle, R.T.; Lerman, C. Interest in genetic testing for colon cancer susceptibility: cognitive and emotional correlates. Prev. Med. 1993, 22, 284-292.
15. Ford, D.; Easton, D.F.; Petro, J.; Narod, S.A.; Goldgar, D.E. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am. J. Hum. Genet. 1995, 57, 1457-1462.
16. Lerman, C.; Daly, M.; Masny, A.; Balshem, A. Attitudes about genetic testing for breast-ovarian susceptibility. J. Clin. Oncol. 1994, 12, 843-850.
17. King, M.C.; Rowell, S.; Love, S.M. Inherited breast and ovarian cancer: What are the risks? What are the choices? J. Am. Med. Assoc. 1993, 269, 1975-1980.
18. Grann, V.R.; Panageas, K.S.; Whang, W.; Antman, K.H.; Neugut, A.I. Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients. J. Clin. Oncol. 1998, 16, 979-985.
19. Bredart, A.; Autier, P.; Riccardo, A.; Audisio, A. Psychosocial dimensions of BRCA testing: an over-shadowed issue. Eur. J. Cancer Care 2001, 26, 96-99.
20. Andrykowski, M.A.; Munn, R.K.; Studts, J.L. Interest in learning of personal genetic risk for cancer: a general population survey. Prev. Med. 1996, 25, 527-536.
21. Chaliki, H.; Loader, S.; Levenkron, J.C.; Logan-Young, W.; Hall, W.J.; Rowley, P.T. Women's receptivity to testing for a genetic susceptibility to breast cancer. Am. J. Public Health 1995, 85, 1133-1135.
22. Julian-Reynier, C.; Eisinger, F.; Vennin, P.; Chabal, F.; Aurran, Y.; Nogues, C.; Bignon, Y.J.; Machelard-Roumagnac, M.; Maugard-Louboutin, C.; Serin, D.; Blanc, B.; Orsoni, P.; Sobol, H. Attitudes towards cancer predictive testing and transmission of information to the family. J. Med. Genet. 1996, 33, 731-736.
23. Struewing, J.P.; Lerman, C.; Kase, R.G.; Giambaressi, T.R.; Tucker, M.A. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol. Biomarkers Prev. 1995, 4, 169-173.
24. Schwartz, M.D.; Benkendort, J.; Lerman, C.; Issacs, C.; Ryan-Robertson, A.; Johnson, L. Impact of educational print materials on knowledge, attitudes, and interest in BRCA1/BRCA2 testing among Ashkenazi Jewish women. Cancer 2001, 92, 932-940.
25. Durfy, S.J.; Bowen, D.J.; McTiernan, A.; Sporleder, J.; Burke, W. Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. Cancer Epidemiol. Biomarkers Prev. 1999, 8, 369-375.
26. Burke, W.; Culver, J.O.; Bowen, D.; Lowry, D.; Durfy, S.; McTiernan, A.; Andersen, M.R. Genetic counseling for women with an intermediate family history of breast cancer. Am. J. Med. Genet. 2000, 90, 361-368.
27. Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer. Cancer Epidemiol. Biomarkers Prev. 1999, 8, 533-539.
28. Bluman, L.G.; Rimer, B.K.; Berry, D.A.; Borstelmann, N.; Iglehart, D.; Regan, K.; Schildkraut, J.; Winer, E.P. Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2. J. Clin. Oncol. 1999, 17, 1040-1046.
29. Lerman, C.; Biesecker, B.; Benkendorf, J.L.; Kerner, J.; Gomez-Caminero, A.; Hughes, C.; Reed, M.M. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. J. Natl Cancer Inst. 1997, 89, 148-157.
30. Jacobsen, P.B.; Valdimarsdottir, H.B.; Brown, K.L.; Offit, K. Decision-making about genetic testing among women at familial risk for breast cancer. Psychosomat. Med. 1997, 59, 459-466.
31. Cappelli, M.; Surh, L.; Humphreys, L.; Verma, S.; Logan, D.; Hunter, A.; Allanson, J. Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer. Clin. Genet. 1999, 55, 419-430.
32. Tambor, E.S.; Rimer, B.K.; Strigo, T.S. Genetic testing for breast cancer susceptibility: awareness and interest among women in the general population. Am. J. Med. Genet. 1997, 68, 43-49.
33. Lerman, C.; Hughes, C.; Benkendorf, J.L.; Biesecker, B.; Kerner, J.; Willison, J.; Eads, N.; Hadley, D.; Lynch, J. Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing. Cancer Epidemiol. Biomarkers Prev. 1999, 8, 361-367.
34. Wonderlick, A.L.; Fine, B.A. Knowledge of breast cancer genetics among breast cancer patients and first-degree relatives of affected individuals. J. Genet. Couns. 1997, 6, 111-130.
35. Hughes, C.; Gomez-Caminero, A.; Benkendorf, J.; Kerner, J.; Isaacs, C.; Barter, J.; Lerman, C. Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. Patient Educ. Couns. 1997, 32, 51-62.
36. Alexander, N.E.; Ross, J.; Sumner, W.; Nease, R.F.; Littenberg, B. The effect of an educational intervention on the perceived risk of breast cancer. J. Gen. Intern. Med. 1995, 11, 92-97.
37. Lerman, C.; Lustbader, E.; Rimer, B.; Daly, M.; Miller, S.; Sands, C.; Balshem, A. Effects of individualized breast cancer risk counseling: a randomized trial. J. Natl Cancer Inst. 1997, 87, 286-292.
38. Lerman, C.; Schwartz, M.D.; Miller, S.M.; Sands, C.; Rimer, B.K. A randomized trial of breast cancer risk counseling: interacting effects of counseling, educational level, and coping style. Health Psychol. 1996, 15, 75-83.
39. Geller, G.; Doksum, T.; Bernhardt, B.A.; Metz, S.A. Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions. Cancer Epidemiol. Biomarkers Prev. 1999, 8, 377-383.
40. Lynch, H.T.; Lemon, S.J.; Durham, C.; Tinley, S.T.; Connolly, C.; Lynch, J.F.; Surdam, J.; Orinion, E.; Slominski-Caster, S.; Watson, P.; Lerman, C.; Tonin, P.; Lenoir, G.; Serova, O.; Narod, S. A descriptive study of BRCA1 testing and reactions to disclosure of test results. Cancer 1997, 79, 2219-2228.
41. Robinson, G.E.; Rosen, B.P.; Bradley, L.N.; Rockert, W.G.; Carr, M.L.; Cole, D.E.C.; Murphy, K.J. Psychological impact of screening for familial ovarian cancer: reactions to initial assessment. Gynecol. Oncol. 1997, 65, 197-205.
42. Armstrong, K.; Calzone, K.; Stopfer, J.; Fitzgerald, G.; Coyne, J.; Weber, B. Factors associated with decisions about clinical BRCA1/2 testing. Cancer Epidemiol. Biomarkers Prev. 2000, 9, 1251-1254.
43. Biesecker, B.B.; Ishibe, N.; Hadley, D.W.; Giambarresi, T.R.; Kase, R.G. ; Lerman, C.; Struewing, J.P. Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families. Am. J. Med. Genet. 2000, 93, 257-263.
44. Meijers-Heijboer, E.J.; Verhoog, L.C.; Brekelmans, C.T.M.; Seynaeve, C.; Tilanus-Linthorst, M.M.A.; Wagner, A.; Dukel, L.; Devilee, P.; van den Ouweland, A.M.W.; van Geel, A.N.; Klijn, J.G.M. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet 2000, 355, 2015-2020.
45. Smith, K.E.; West, J.A.; Croyle, R.T.; Botkin, J.R. Familial context of genetic testing for cancer susceptibility: moderating effect of siblings' test results on psychological distress one to two weeks after BRCA1 mutation testing. Cancer Epidemiol. Biomarkers Prev. 1999, 8, 385-392.
46. Lerman, C.; Narod, S.; Schulman, K.; Hughes, C.; Gomez-Caminaro, B.G.; Gold, K.; Trock, B.; Main, D.; Lynch, J.; Fulmore, C.; Snyder, C.; Lemon, S.; Conway, T.; Tonin, P.; Lenoir, G.; Lynch, H. BRCA1 testing in families with hereditary breast-ovarian cancer: a prospective study of patient decision making and outcomes. J. Am. Med. Assoc. 1996, 275, 1885-1892.
47. Schwartz, M.D.; Hughes, C.; Roth, J.; Main, D.; Peshkin, B.N.; Isaacs, C.; Kavanagh, C.; Lerman, C. Spiritual faith and genetic testing decisions among high-risk breast cancer probands. Cancer Epidemiol. Biomarkers Prev. 2000, 9, 381-385.
48. Lerman, C.; Hughes, C.; Lemon, S.J.; Main, D.; Snyder, C.; Durham, C.; Narod, S.; Lynch, H.T. What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing. J. Clin. Oncol. 1998, 16, 1650-1654.
49. Lerman, C.; Schwartz, M.D.; Lin, T.H.; Hughes, C.; Narod, S.; Lynch, H.T. The influence of psychological distress on use of genetic testing for cancer risk. J. Consult. Clin. Psychol. 1997, 65, 414-420.
50. Wagner, T.M.U.; Moslinger, R.; Langbauer, G.; Ahner, R.; Fleischmann, E. ; Auterith, A.; Friedmann, A.; Helbich, T.; Zielinski, C.; Pittermann, E.; Seifert, M.; Oefner, P. Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations. Br. J. Cancer 2000, 82, 1249-1253.
51. Croyle, R.T.; Smith, K.R.; Botkin, J.R.; Baty, B.; Nash, J. Psychological responses to BRCA1 mutation testing: preliminary findings. Health Psychol. 1997, 16, 63-72.
52. Dudok deWit, A.C.; Tibben, A.; Duivenvoorden, H.J.; Frets, P.G.; Zoeteweij, M.W.; Losekoot, M.; van Haeringen, A.; Niermeijer, M.F.; Passchier, J. Psychological distress in applicants for predictive DNA testing for autosomal dominant, heritable, late onset disorders. J. Med. Genet. 1997, 34, 382-390.
53. Dudok deWit, A.C.; Tibben, A.; Duivenvoorden, H.J.; Niermeijer, M.F.; Passchier, J.; Trijsburg, R.W. Distress in individuals facing predictive DNA testing for autosomal dominant late-onset disorders: comparing questionnaire results with in-depth interviews. Am. J. Med. Genet. 1998, 75, 62-74.
54. Lodder, L.N.; Frets, P.G.; Trijsburg, R.W.; Meijers-Heijboer, E.J.; Klijn, J.G.M.; Duivenvoorden, H.J.; Tibben, A.; Wagner, A.; van der Meer, C.A.; Devilee, P.; Cornelisse, C.J.; Niermeijer, M.F. Presymptomatic testing for BRCA1 and BRCA2: How distressing are the pre-test weeks? J. Med. Genet. 1999, 36, 906-913.
55. Lodder, L.N.; Frets, P.G.; Trijsburg, R.W.; Meijers-Heijboer, E.J.; Klijn, J.G.M.; Duivenvoorden, H.J.; Tibben, A.; Wagner, A.; van der Meer, C.A.; van den Ouweland, A.M.W.; Niermeijer, M.F. Psychological impact of receiving a BRCA1/2 test result. Am. J. Med. Genet. 2001, 98, 15-24.
56. Lerman, C.; Croyle, R. Psychological issues in genetic testing for breast cancer susceptibility. Arch. Intern. Med. 1994, 154, 609-616.
57. Baum, A.; Friedman, A.L.; Zakowski, S.G. Stress and genetic testing for disease risk. Health Psychol. 1997, 16, 8-19.
58. Dudok deWit, A.C.; Duivenvoorden, H.J.; Passchier, J.; Niermeijer, M.F.; Tibben, A. Course of distress experienced by persons at risk for an autosomal dominant inheritable disorder participating in a predictive testing program: an explorative study. Psychosomat. Med. 1998, 60, 543-549.
59. Dudok deWit, A.C.; Tibben, A.; Duivenvoorden, H.J.; Niermeijer, M.F.; Passchier, J. Predicting adaptation to presymptomatic DNA testing for late onset disorders: Who will experience distress? J. Med. Genet. 1998, 35, 745-754.
60. Dorval, M.; Patenaude, A.F.; Schneider, K.A.; Kieffer, S.A.; DiGianni, L.; Kalkbrenner, K.J.; Bromberg, J.I.; Basili, L.A.; Calzone, K.; Stopfer, J.; Weber, B.L.; Garber, J.E. Anticipated versus actual emotional reactions to disclosure of results of cancer susceptibility: finding from p53 and BRCA1 testing programs. J. Clin. Oncol. 2000, 18, 2135-2142.
61. Hughes, C.; Lynch, H.; Durham, C.; Snyder, C.; Lemon, S.; Narod, S.; Fulmore, C.; Main, D.; Lerman, C. Communication of BRCA1/2 test results in hereditary breast cancer families. Cancer Res. Ther. Control 1999, 8, 51-59.
62. Lerman, C.; Peshkin, B.N.; Hughes, C.; Isaacs, C. Family disclosure in genetic testing for cancer susceptibility: determinants and consequence. J. Health Care Law 1998, 1, 353-372.
63. Tercyak, K.P.; Hughes, C.; Main, D.; Snyder, C.; Lynch, J.F.; Lynch, H.T.; Lerman, C. Parental communication of BRCA1/2 genetic test results to children. Patient Educ. Couns. 2001, 42, 213-224.
64. Lynch, H.T.; Watson, T.; Conway, A.; Lynch, J.F.; Slominski-Caster, S.M. ; Narod, S.A.; Feunteun, J.; Lenoir, G. DNA screening for breast/ovarian cancer susceptibility based on linked markers: a family study. Arch. Intern. Med. 1993, 153, 1979-1987.
65. Metcalfe, K.; Liede, A.; Hoodfar, E.; Scott, A.; Foulkes, W.D.; Narod, S.A. An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counseling. J. Med. Genet. 2000, 37, 866-874.
66. Lerman, C.; Hughes, C.; Croyle, R.T.; Main, D.; Durham, C.; Snyder, C.; Bonney, A.; Lynch, J.F.; Narod, S.A.; Lynch, H.T. Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Prev. Med. 2000, 31, 75-80.
67. Rolland, J.S. Anticipatory loss: a family systems developmental framework. Fam. Process 1990, 29, 229-244.
68. Liede, A.; Metcalfe, K.; Hanna, D.; Hoodfar, E.; Synder, C.; Durham, C.; Lynch, H.T.; Narod, S.A. Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling. Am. J. Hum. Genet. 2000, 67, 1494-1504.